Molecular mechanisms and therapeutic targets for diabetic kidney disease
Katherine R. Tuttle(University of Washington), Jaime Uribarri(Icahn School of Medicine at Mount Sinai)
Cited by 609
Related Papers
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
|New England Journal of Medicine|2024|1.5k
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
|American Journal of Kidney Diseases|2014|896
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
|Endocrine Practice|2022|465
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
|Kidney International|2013|350
Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children
|JAMA Network Open|2019|256